Related Experiment Video
Updated: Jul 12, 2026
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Toxicogenomics of A375 human malignant melanoma cells
Sun-Long Cheng1, Rosa Huang-Liu, Jin-Nan Sheu
1Chung Shan Medical University, Department of Plastic Surgery, Chung Shan Medical University Hospital, Taichung, 40242, Taiwan.
Abstract:
Toxicogenomics applications are increasingly applied to the evaluation of preclinical drug safety, and to explain toxicities associated with compounds at the mechanism level. In this review, we aim to describe the application of toxicogenomics tools for studying the genotoxic effect of active compounds on the gene-expression profile of A375 human malignant melanoma cells, through the other molecular functions of target genes, regulatory pathways and mechanisms of malignant melanomas. It also includes the current systems biology approaches, which are very useful for analyzing the biological system and understanding the entire mechanisms of malignant melanomas. We believe that this review would be very potent and useful for studying the toxicogenomics of A375 melanoma cells, and for further diagnostic and therapeutic applications.
Insights
Toxicogenomics aids preclinical drug safety by revealing compound toxicity mechanisms. This review explores its use in understanding genotoxic effects on A375 melanoma cells, aiding future diagnostics and therapies.
Area of Science:
- Toxicology
- Genomics
- Melanoma Research
Background:
- Toxicogenomics is vital for preclinical drug safety assessment.
- Understanding compound toxicity at the molecular mechanism level is crucial.
- A375 human malignant melanoma cells are a relevant model for studying genotoxicity.
Purpose of the Study:
- To review toxicogenomics applications for assessing genotoxic effects on A375 melanoma cells.
- To explore target gene functions, regulatory pathways, and melanoma mechanisms.
- To highlight the utility of systems biology approaches in this context.
Main Methods:
- Review of toxicogenomics studies.
- Analysis of gene-expression profiles in A375 cells.
- Integration of systems biology approaches.
Main Results:
- Toxicogenomics provides insights into genotoxic compound effects on melanoma cells.
- Gene expression analysis reveals molecular functions and pathways involved in toxicity.
- Systems biology enhances understanding of complex melanoma mechanisms.
Conclusions:
- Toxicogenomics is a powerful tool for studying A375 melanoma cell genotoxicity.
- This approach aids in understanding molecular mechanisms of drug-induced toxicity.
- Findings support future diagnostic and therapeutic applications in melanoma treatment.
